Karim Saad Temsamani - Oct 1, 2023 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Executive Officer, Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Oct 1, 2023
Transactions value $
-$408,993
Form type
4
Date filed
10/3/2023, 06:27 PM
Previous filing
Sep 11, 2023
Next filing
Dec 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Options Exercise +50K +25.8% 244K Oct 1, 2023 Direct F1
transaction CDLX Common Stock Sale -$210K -15.5K -6.34% $13.55 228K Oct 2, 2023 Direct F2, F3
transaction CDLX Common Stock Sale -$124K -8.3K -3.64% $14.92 220K Oct 2, 2023 Direct F2, F4
transaction CDLX Common Stock Sale -$73.9K -4.71K -2.14% $15.70 215K Oct 2, 2023 Direct F2, F5
transaction CDLX Common Stock Sale -$1.73K -106 -0.05% $16.35 215K Oct 2, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Units Options Exercise $0 -50K -33.33% $0.00 100K Oct 1, 2023 Common Stock 50K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
F2 Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on October 1, 2023.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.21 to $14.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.27 to $15.265, inclusive.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.275 to $16.23, inclusive.
F6 This RSU award was originally for 200,000 shares. 25% of the RSU award vested on each of July 1, 2023 and October 1, 2023. An additional 25% of the RSU award shall vest on each of January 1, 2024 and April 1, 2024, respectively, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date.